Search research articles
Contact Us
Filters
Showing results (131-140 of 205) with videos related to
Page
of 21
Sort By:
Journal for Immunotherapy of Cancer
|
October 12, 2018
Immune-related adverse events with immune checkpoint inhibitors affecting the skeleton: a seminal case series
Kendall F Moseley, Jarushka Naidoo, Clifton O Bingham, et al.
Journal for Immunotherapy of Cancer
|
October 16, 2014
Ipilimumab administration for advanced melanoma in patients with pre-existing Hepatitis B or C infection: a multicenter, retrospective case series
Sowmya Ravi, Kristen Spencer, Mary Ruisi, et al.
Molecular Oncology
|
August 17, 2018
From validity to clinical utility: the influence of circulating tumor DNA on melanoma patient management in a real-world setting
Steven P Rowe, Brandon Luber, Monique Makell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 22, 2012
Durable cancer regression off-treatment and effective reinduction therapy with an anti-PD-1 antibody
Evan J Lipson, William H Sharfman, Charles G Drake, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 22, 2017
PD-L1 Expression in Melanoma: A Quantitative Immunohistochemical Antibody Comparison
Joel C Sunshine, Peter L Nguyen, Genevieve J Kaunitz, et al.
Cancer Immunology Research
|
January 14, 2014
PD-L1 expression in the Merkel cell carcinoma microenvironment: association with inflammation, Merkel cell polyomavirus and overall survival
Evan J Lipson, Jeremy G Vincent, Myriam Loyo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 29, 2019
Major pathologic response on biopsy (MPRbx) in patients with advanced melanoma treated with anti-PD-1: evidence for an early, on-therapy biomarker of response
J E Stein, A Soni, L Danilova, et al.
Annals of the Rheumatic Diseases
|
June 17, 2016
Inflammatory arthritis and sicca syndrome induced by nivolumab and ipilimumab
Laura C Cappelli, Anna Kristina Gutierrez, Alan N Baer, et al.
The British Journal of Dermatology
|
July 27, 2025
Merkel Cell Carcinoma in Solid Organ Transplant Recipients: Prognosis and Response to Immunotherapy
Tomoko Akaike, Peter Y Ch'en, Daniel S Hippe, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 11, 2023
Health-related quality of life with nivolumab plus relatlimab versus nivolumab monotherapy in patients with previously untreated unresectable or metastatic melanoma: RELATIVITY-047 trial
Dirk Schadendorf, Hussein Tawbi, Evan J Lipson, et al.
Page
of 21
Search research articles
Search
Showing results (131-140 of 205) with videos related to
Sort By:
Page
of 21
Journal for Immunotherapy of Cancer
|
October 12, 2018
Immune-related adverse events with immune checkpoint inhibitors affecting the skeleton: a seminal case series
Kendall F Moseley, Jarushka Naidoo, Clifton O Bingham, et al.
Journal for Immunotherapy of Cancer
|
October 16, 2014
Ipilimumab administration for advanced melanoma in patients with pre-existing Hepatitis B or C infection: a multicenter, retrospective case series
Sowmya Ravi, Kristen Spencer, Mary Ruisi, et al.
Molecular Oncology
|
August 17, 2018
From validity to clinical utility: the influence of circulating tumor DNA on melanoma patient management in a real-world setting
Steven P Rowe, Brandon Luber, Monique Makell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 22, 2012
Durable cancer regression off-treatment and effective reinduction therapy with an anti-PD-1 antibody
Evan J Lipson, William H Sharfman, Charles G Drake, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 22, 2017
PD-L1 Expression in Melanoma: A Quantitative Immunohistochemical Antibody Comparison
Joel C Sunshine, Peter L Nguyen, Genevieve J Kaunitz, et al.
Cancer Immunology Research
|
January 14, 2014
PD-L1 expression in the Merkel cell carcinoma microenvironment: association with inflammation, Merkel cell polyomavirus and overall survival
Evan J Lipson, Jeremy G Vincent, Myriam Loyo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 29, 2019
Major pathologic response on biopsy (MPRbx) in patients with advanced melanoma treated with anti-PD-1: evidence for an early, on-therapy biomarker of response
J E Stein, A Soni, L Danilova, et al.
Annals of the Rheumatic Diseases
|
June 17, 2016
Inflammatory arthritis and sicca syndrome induced by nivolumab and ipilimumab
Laura C Cappelli, Anna Kristina Gutierrez, Alan N Baer, et al.
The British Journal of Dermatology
|
July 27, 2025
Merkel Cell Carcinoma in Solid Organ Transplant Recipients: Prognosis and Response to Immunotherapy
Tomoko Akaike, Peter Y Ch'en, Daniel S Hippe, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 11, 2023
Health-related quality of life with nivolumab plus relatlimab versus nivolumab monotherapy in patients with previously untreated unresectable or metastatic melanoma: RELATIVITY-047 trial
Dirk Schadendorf, Hussein Tawbi, Evan J Lipson, et al.
Page
of 21